GlassScriptPhysician profile
Christopher Michael Foth
NPI 1548791460
$6,881.16
in general payments reported to CMS, 2019-2025
20 companies · $528 in 2025
The $528 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $28.19 · 2021: $798 · 2022: $1,635 · 2023: $2,504 · 2024: $1,025 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,659 · Grant: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,658.65 |
| Grant | $1,398.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,150.77 | 2021-2024 | Onyx Frontier, Endurant Iis |
| Boston Scientific Corporation | $1,877.52 | 2021-2024 | Rotablator Rotational Atherectomy System Console Kit |
| Astrazeneca Pharmaceuticals LP | $462.75 | 2019-2025 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $265.78 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $261.92 | 2025 | Assure Wcd |
| Abiomed | $260.02 | 2023-2024 | Impella |
| Asahi Intecc USA, INC. | $237.96 | 2024 | Peripheral Vascular |
| Amgen INC. | $236.42 | 2021-2023 | Repatha |
| W. L. Gore & Associates, INC. | $191.07 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Pfizer INC. | $160.00 | 2019-2021 | |
| Edwards Lifesciences Corporation | $157.24 | 2024 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $133.87 | 2025 | |
| Surmodics, INC. | $117.13 | 2023 | Sublime Radial Access Guide Sheath, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Shockwave Medical, INC | $101.33 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $64.13 | 2022 | |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Stryker Corporation | $41.59 | 2025 | Flowtriever |
| Terumo Medical Corporation | $22.20 | 2022 | |
| Organogenesis INC. | $19.46 | 2025 | Apligraf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Foth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.